Uzma Salar

3.1k total citations
118 papers, 2.6k citations indexed

About

Uzma Salar is a scholar working on Organic Chemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Uzma Salar has authored 118 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Organic Chemistry, 36 papers in Molecular Biology and 25 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Uzma Salar's work include Synthesis and biological activity (66 papers), Synthesis and Characterization of Heterocyclic Compounds (28 papers) and Natural Antidiabetic Agents Studies (23 papers). Uzma Salar is often cited by papers focused on Synthesis and biological activity (66 papers), Synthesis and Characterization of Heterocyclic Compounds (28 papers) and Natural Antidiabetic Agents Studies (23 papers). Uzma Salar collaborates with scholars based in Pakistan, Saudi Arabia and Malaysia. Uzma Salar's co-authors include Khalid Mohammed Khan, Muhammad Taha, Shahnaz Perveen, Abdul Wadood, Nor Hadiani Ismail, Sridevi Chigurupati, Kanwal, Syahrul Imran, Muhammad Riaz and Farman Ali and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Biological Macromolecules.

In The Last Decade

Uzma Salar

112 papers receiving 2.6k citations

Peers

Countries citing papers authored by Uzma Salar

Since Specialization

Citations

This map shows the geographic impact of Uzma Salar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uzma Salar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uzma Salar more than expected).

Fields of papers citing papers by Uzma Salar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uzma Salar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uzma Salar. The network helps show where Uzma Salar may publish in the future.

Co-authorship network of co-authors of Uzma Salar

This figure shows the co-authorship network connecting the top 25 collaborators of Uzma Salar. A scholar is included among the top collaborators of Uzma Salar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uzma Salar. Uzma Salar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Saturation transfer difference (STD)-NMR spectroscopy in drug discovery: A comprehensive review on identified potential hits based on natural and synthetic scaffolds against therapeutic drug targets 2025 ·Bioorganic & Medicinal Chemistry ·Salar Hafez Ghoran, Uzma Salar	1
2	Piperonal-derived (E)-2-(2-(Benzo[d][1,3]dioxol-5-ylmethylene)hydrazineyl)-4-(aryl)thiazole derivatives as potential therapeutic leads for diabetes and Alzheimer's disease: In vitro and in silico evaluation against α-glucosidase, α-amylase, acetylcholinesterase, and butyrylcholinesterase 2025 ·Journal of Molecular Structure ·Asif Ahmad, Uzma Salar, Musa Özil, Nimet Baltaş, (unknown), Zaheer Ul‐Haq, Khalid Mohammed Khan, Farzana Shaheen	0
3	Design, synthesis, and biological evaluation of 3-phenylimidazo[1,2-a]pyridine derivatives as diverse enzyme inhibitors 2025 ·Journal of the Iranian Chemical Society ·Muhammad Ali, Khalid Mohammed Khan, Parham Taslımı, Shahbaz Shamim, Uzma Salar, Tuğba Taşkın‐Tok, Syed Muhammad Saad, Muhammad Taha	0
4	2-amino-6-ethoxy-4-arylpyridine-3,5-dicarbonitrile Scaffolds as potential acetylcholinesterase and butyrylcholinesterase inhibitors 2024 ·Journal of Molecular Structure ·Muhammad Ali, Shahbaz Shamim, Uzma Salar, Parham Taslımı, Syed Muhammad Saad, Tuğba Taşkın‐Tok, Muhammad Taha, Khalid Mohammed Khan	8
5	Nicotinonitriles as potential inhibitors of α-glucosidase, tyrosinase, and urease enzymes: Synthesis, characterization, in vitro, and in silico studies 2024 ·Journal of Molecular Structure ·(unknown), Nida Ambreen, Faiza Saleem, Muhammad Arif Lodhi, Faheem Jan, (unknown), Uzma Salar, Muhammad Taha, Khalid Mohammed Khan	4
6	Rhodanine-benzamides as potential hits for α-amylase enzyme inhibitors and radical (DPPH and ABTS) scavengers 2024 ·Molecular Diversity ·(unknown), (unknown), Khalid Mohammed Khan, Sridevi Chigurupati, (unknown), Uzma Salar, Zaheer Ul‐Haq, Suliman A. Almahmoud, Shatha Ghazi Felemban, (unknown), Muhammad Taha	0
7	Regioselective syntheses of 2-oxopyridine carbonitrile derivatives and evaluation for antihyperglycemic and antioxidant potential 2023 ·International Journal of Biological Macromolecules ·Faiza Saleem, (unknown), Khalid Mohammed Khan, Musa Özil, Nimet Baltaş, Zaheer Ul‐Haq, (unknown), Uzma Salar, Muhammad Taha, Shehryar Hameed, Nisar Ullah	13
8	Synthetic piperidine-substituted Chalcones As Potential Hits for α-amylase Inhibitory and Antioxidant Activities 2023 ·Future Medicinal Chemistry ·(unknown), (unknown), Uzma Salar, Sridevi Chigurupati, (unknown), Suliman A. Almahmoud, Shehryar Hameed, (unknown), Manzoor Ahmad, (unknown), Zaheer Ul‐Haq, Khalid Mohammed Khan	4
9	Synthesis of new bis(dimethylamino)benzophenone hydrazone for diabetic management: In-vitro and in-silico approach 2023 ·Heliyon ·Momin Khan, (unknown), Aftab Alam, (unknown), Ajmal Khan, Kanwal, Uzma Salar, Abdul Wadood, Amar Ajmal, (unknown), Shahnaz Perveen, Jalal Uddin, Ahmed Al‐Harrasi	31
10	Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities 2022 ·International Journal of Biological Macromolecules ·Shehryar Hameed, Khalid Mohammed Khan, Uzma Salar, Musa Özil, Nimet Baltaş, Faiza Saleem, (unknown), Muhammad Taha, Zaheer Ul‐Haq	28
11	Evaluation of synthetic 2-aryl quinoxaline derivatives as α-amylase, α-glucosidase, acetylcholinesterase, and butyrylcholinesterase inhibitors 2022 ·International Journal of Biological Macromolecules ·Shehryar Hameed, Khalid Mohammed Khan, Parham Taslımı, Uzma Salar, Tuğba Taşkın‐Tok, Dursun Kısa, Faiza Saleem, Mehwish Solangi, (unknown), (unknown)	34
12	Synthesis and screening of (E)-3-(2-benzylidenehydrazinyl)-5,6-diphenyl-1,2,4-triazine analogs as novel dual inhibitors of α-amylase and α-glucosidase 2020 ·Bioorganic Chemistry ·Shahbaz Shamim, Khalid Mohammed Khan, Nisar Ullah, Sridevi Chigurupati, Abdul Wadood, Ashfaq Ur Rehman, Muhammad Ali, Uzma Salar, Ahmad Alhowail, Muhammad Taha, Shahnaz Perveen	38
13	ROS Inhibitory Activity and Cytotoxicity Evaluation of Benzoyl, Acetyl, Alkyl Ester, and Sulfonate Ester Substituted Coumarin Derivatives 2019 ·Medicinal Chemistry ·Uzma Salar, Khalid Mohammed Khan, Almas Jabeen, (unknown), (unknown), Shakil Ahmed, Erum Iqbal, Farman Ali, Kanwal, Shahnaz Perveen	5
14	Benzylidine indane-1,3-diones: As novel urease inhibitors; synthesis, in vitro, and in silico studies 2018 ·Bioorganic Chemistry ·(unknown), Kanwal, Khalid Mohammed Khan, Farida Begum, Muhammad Arif Lodhi, Uzma Salar, Ruqaiya Khalil, Zaheer Ul‐Haq, Shahnaz Perveen	13
15	Chalcones and bis-chalcones: As potential α-amylase inhibitors; synthesis, in vitro screening, and molecular modelling studies 2018 ·Bioorganic Chemistry ·(unknown), Khalid Mohammed Khan, Uzma Salar, Sridevi Chigurupati, T.M. Fasina, Farman Ali, Kanwal, Abdul Wadood, Muhammad Taha, Sitansu Sekhar Nanda, Mehreen Ghufran, Shahnaz Perveen	48
16	Biology-oriented drug synthesis (BIODS), in vitro urease inhibitory activity, and in silico study of S-naproxen derivatives 2018 ·Bioorganic Chemistry ·Ghulam Mohiuddin, Khalid Mohammed Khan, Uzma Salar, Kanwal, Muhammad Arif Lodhi, Abdul Wadood, Muhammad Riaz, Shahnaz Perveen	26
17	Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies 2017 ·Bioorganic & Medicinal Chemistry ·Humaira Zafar, Muhammad Abid Hayat, Sumayya Saied, Momin Khan, Uzma Salar, (unknown), M. Iqbal Choudhary, Khalid Mohammed Khan	32
18	Synthesis, in vitro β -glucuronidase inhibitory activity and in silico studies of novel ( E )-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles 2017 ·Bioorganic Chemistry ·Uzma Salar, Khalid Mohammed Khan, (unknown), Muhammad Taha, Farman Ali, Nor Hadiani Ismail, Shahnaz Perveen, Abdul Wadood, Mehreen Ghufran	10
19	Coumarin and Biscoumarin Inhibit <i>in Vitro</i> Obesity Model 2016 ·Advances in Biological Chemistry ·(unknown), Kimberly A. Stieglitz, Shamsher Ali, Asma Ejaz, M. Iqbal Choudhary, Muhammad Fakhri, Uzma Salar, Khalid Mohammed Khan	10
20	Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies 2016 ·Bioorganic Chemistry ·Muhammad Taha, Nor Hadiani Ismail, Syahrul Imran, (unknown), Waqas Jamil, Sajjad Ali, Syed Muhammad Kashif, Fazal Rahim, Uzma Salar, Khalid Mohammed Khan	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact